These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 39325128)

  • 21. Mouse Breast Carcinoma Monocytic/Macrophagic Myeloid-Derived Suppressor Cell Infiltration as a Consequence of Endothelial Dysfunction in
    He Q; Jamalpour M; Bergquist E; Anderson RL; Gustafsson K; Welsh M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic Reprogramming in Tumor Endothelial Cells.
    García-Caballero M; Sokol L; Cuypers A; Carmeliet P
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiocrine endothelium: from physiology to cancer.
    Pasquier J; Ghiabi P; Chouchane L; Razzouk K; Rafii S; Rafii A
    J Transl Med; 2020 Feb; 18(1):52. PubMed ID: 32014047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment.
    Marech I; Leporini C; Ammendola M; Porcelli M; Gadaleta CD; Russo E; De Sarro G; Ranieri G
    Cancer Lett; 2016 Sep; 380(1):216-26. PubMed ID: 26238184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia control to normalize pathologic angiogenesis: potential role for endothelial precursor cells and miRNAs regulation.
    Collet G; Skrzypek K; Grillon C; Matejuk A; El Hafni-Rahbi B; Lamerant-Fayel N; Kieda C
    Vascul Pharmacol; 2012; 56(5-6):252-61. PubMed ID: 22446152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor endothelial cells accelerate tumor metastasis.
    Maishi N; Hida K
    Cancer Sci; 2017 Oct; 108(10):1921-1926. PubMed ID: 28763139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered angiogenesis in the tumor microenvironment.
    Hida K; Kawamoto T; Ohga N; Akiyama K; Hida Y; Shindoh M
    Pathol Int; 2011 Nov; 61(11):630-7. PubMed ID: 22029673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disturbed endothelial cell signaling in tumor progression and therapy resistance.
    Fischer A; Alsina-Sanchis E
    Curr Opin Cell Biol; 2024 Feb; 86():102287. PubMed ID: 38029706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microvascular Mural Cells in Cancer.
    Östman A; Corvigno S
    Trends Cancer; 2018 Dec; 4(12):838-848. PubMed ID: 30470305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct and indirect regulation of the tumor immune microenvironment by VEGF.
    Zhang Y; Brekken RA
    J Leukoc Biol; 2022 Jun; 111(6):1269-1286. PubMed ID: 35466428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-edged sword in tumor angiogenesis and progression. Dual roles of mast cells, macrophages, and neutrophils.
    Ribatti D
    Pathol Res Pract; 2022 Dec; 240():154167. PubMed ID: 36343459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor endothelial cell-derived extracellular vesicles contribute to tumor microenvironment remodeling.
    Gao J; Zhang X; Jiang L; Li Y; Zheng Q
    Cell Commun Signal; 2022 Jun; 20(1):97. PubMed ID: 35752798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response.
    Geindreau M; Ghiringhelli F; Bruchard M
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual role of endothelial
    Kabir AU; Subramanian M; Lee DH; Wang X; Krchma K; Wu J; Naismith T; Halabi CM; Kim JY; Pulous FE; Petrich BG; Kim S; Park HC; Hanson PI; Pan H; Wickline SA; Fremont DH; Park C; Choi K
    Sci Transl Med; 2021 Mar; 13(583):. PubMed ID: 33658356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological angiogenesis and inflammation in tissues.
    Jeong JH; Ojha U; Lee YM
    Arch Pharm Res; 2021 Jan; 44(1):1-15. PubMed ID: 33230600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Intersection between Tumor Angiogenesis and Immune Suppression.
    Rahma OE; Hodi FS
    Clin Cancer Res; 2019 Sep; 25(18):5449-5457. PubMed ID: 30944124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of miRNAs in tumor and endothelial cell interactions during tumor progression.
    Orso F; Quirico L; Dettori D; Coppo R; Virga F; Ferreira LC; Paoletti C; Baruffaldi D; Penna E; Taverna D
    Semin Cancer Biol; 2020 Feb; 60():214-224. PubMed ID: 31386907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial cells in tumor microenvironment: insights and perspectives.
    Leone P; Malerba E; Susca N; Favoino E; Perosa F; Brunori G; Prete M; Racanelli V
    Front Immunol; 2024; 15():1367875. PubMed ID: 38426109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting immune suppressing myeloid-derived suppressor cells in oncology.
    Kao J; Ko EC; Eisenstein S; Sikora AG; Fu S; Chen SH
    Crit Rev Oncol Hematol; 2011 Jan; 77(1):12-9. PubMed ID: 20304669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The origins of vacularization in tumors.
    Liu J; Huang J; Yao WY; Ben QW; Chen DF; He XY; Li L; Yuan YZ
    Front Biosci (Landmark Ed); 2012 Jun; 17(7):2559-65. PubMed ID: 22652798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.